|
| |
Janssen Pharmaceutica N.VWe are part of the world’s largest healthcare company, Johnson & Johnson, and enjoy an international reputation for pharmaceutical innovation and quality. For instance, EPREX™ , a breakthrough in the treatment of anaemia, has helped hundreds of thousands of patients and achieved sales of more than US$3 billion. And RISPERDAL™ , an innovative medicine for schizophrenia, won the first-ever International Prix Galien for outstanding pharmaceutical achievement.
| Contact Details: |
| 19, Green Belt Drive |
| North York |
| Ontario |
| M3C1L9 |
| Canada |
| Tel: | (1+416) 449 94 44 |
| Fax: | (1+416) 449 26 58 |
| Email: | cacteam@janus.jnj.com |
| WWW: | www.janssenpharmaceutica.be/
|
|
Loading...
|
Recent Publications by Janssen Pharmaceutica N.V: |  |
Conformational analysis of macrocycles: finding what common search methods miss.
As computational drug design becomes increasingly reliant on virtual... | 8th October, 2009
| Johnson & Johnson Pharmaceutical Research and Development, Division of
| J Chem Inf Model. 2009 Oct;49(10):2242-59.
DOI Direct Link |
Corticotropin releasing factor-induced ERK phosphorylation in AtT20 cells occurs via a cAMP-dependent mechanism requiring EPAC2.
CRF-induced ERK phosphorylation has been shown to be an important... | 4th July, 2009
| CNS Discovery Research, Johnson & Johnson Pharmaceutical Research and
| Neuropharmacology. 2010 Jan;58(1):135-44. Epub 2009 Jun 30.
DOI Direct Link |
In vitro studies on the metabolism of trabectedin (YONDELIS) in monkey and man, including human CYP reaction phenotyping.
Trabectedin (YONDELIS) is a potent anticancer agent which was recently... | 23rd May, 2009
| Johnson & Johnson Pharmaceutical Research and Development (J&JPRD), A
| Biochem Pharmacol. 2009 May 15;77(10):1642-54. Epub 2009 Mar 10.
DOI Direct Link |
Which human metabolites have we MIST? Retrospective analysis, practical aspects, and perspectives for metabolite identification and quantification in pharmaceutical development.
With the recent publication of the FDA guidance on metabolites in safety... | 9th May, 2009
| Department of Drug Metabolism and Pharmacokinetics, Global Preclinical
| Chem Res Toxicol. 2009 Feb;22(2):280-93.
DOI Direct Link |
In vivo, in vitro and in silico methods for small molecule transfer across the BBB.
The inability of molecules to permeate the BBB is a significant source of... | 2nd May, 2009
| ChemPharm development, Johnson & Johnson Pharmaceutical Research &
| J Pharm Sci. 2009 Dec;98(12):4429-68.
DOI Direct Link |
→View more Janssen Pharmaceutica N.V research publications. |
Press Releases on Janssen Pharmaceutica N.V:
|
 |
| Johnson & Johnson Honors 2009 Recipient of The Dr. Paul Janssen Award for Biomedical Research |
8th September, 2009 |
Johnson & Johnson |
-- Sir Richard Sykes, Ph.D., chair, National Health Service, London; former
rector Imperial College London; former chief executive officer,
GlaxoWellcome; fellow of the Royal
|
| Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research |
1st July, 2009 |
Johnson & Johnson |
LONDON, July 1 /PRNewswire/ -- Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany,
|
| Unique Collaboration Between TB Alliance and Tibotec To Accelerate Tuberculosis Drug Development |
17th June, 2009 |
Tibotec Inc. |
Collaboration will focus on the development of TMC207 and the discovery of new drugs to treat tuberculosis
SEATTLE, June 17 /PRNewswire/ -- A new landmark collaboration between the Global Alliance
|
| USPTO Confirms Validity of Bystolic(R) Patent |
24th November, 2008 |
Forest Laboratories, Inc. |
NEW YORK, Nov. 24, 2008 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) announced today that the U.S. Patent and Trademark Office ("USPTO") has closed prosecution on the
|
| WuXi PharmaTech Expands Collaboration for Fully Integrated Services |
16th October, 2008 |
WuXi PharmaTech (Cayman) Inc. |
SHANGHAI, China, Oct. 16 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman)
Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device
research and development outsourcing company
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 14 individuals from Janssen Pharmaceutica N.V using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 344 times since April 2007, the link to the organisation's website has been followed 60 times Recent Search Terms used to find this page: US 6545040 | . Search for more companies in North York Search for more companies in Ontario This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Janssen Pharmaceutica N.V |
